ARWRARROWHEAD PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ARROWHEAD PHARMACEUTICALS, INC. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARWRThis | $12.0B#4 | — | 19.6x#5 | 14.5x#4 | 23258.2%#1 | 99.7%#3 | 11.9%#4 | -0.3%#4 | — | — | 444.0%#1 | — |
| TGTX | $8.3B#7 | 18.9x#1 | 14.2x#3 | 13.4x#3 | 87.3%#2 | 1811.1%#1 | 20.0%#2 | 76.7%#1 | 13.9%#2 | — | 48.8%#2 | — |
| INSM | $21.7B#3 | — | 30.7x#8 | 35.7x#5 | 66.7%#3 | -39.7%#6 | -205.6%#5 | -181.1%#8 | -185.1%#4 | 4#1 | — | — |
| SRRK | $5.9B#9 | — | 21.2x#7 | — | — | -53.7%#8 | — | -137.0%#6 | -901.6%#5 | — | 29.3%#3 | — |
| APGE | $10.0B#6 | — | — | — | — | -40.5%#7 | — | — | — | — | — | — |
| SMMT | $10.4B#5 | — | 16.6x#4 | — | — | -387.8%#9 | — | -171.4%#7 | — | — | — | — |
| UTHR | $22.2B#2 | 19.3x#2 | 3.8x#1 | 7.0x#1 | 10.6%#5 | 11.7%#4 | 46.9%#1 | 22.6%#3 | — | — | — | — |
| COGT | $6.9B#8 | — | 11.4x#2 | 876.8x#6 | -65.0%#6 | -28.6%#5 | -4235.3%#6 | -54.1%#5 | -81.2%#3 | — | — | — |
| ALNY | $27.3B#1 | 35.5x#3 | 20.2x#6 | 7.3x#2 | 65.2%#4 | 212.8%#2 | 13.5%#3 | 23.2%#2 | 150.5%#1 | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-07-31.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice